Author:
Mizunaga Shingo,Kamiyama Tomoko,Fukuda Yoshiko,Takahata Masahiro,Mitsuyama Junichi
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Reference24 articles.
1. Alvarez-Lerma, F., Pavesi, M., Calizay, M. et al. (2001). Risk and prognostic factors of Pseudomonas aeruginosa bacteremia in critically ill patients. Medicina Clinica117, 721–6.
2. Kowalik, M., Ellert-Zygadlowska, J., Smiatacz, T. et al. (2001). Staphylococcus aureus sepsis-still life threatening disease. Polski Merkuriusz Lekarski11, 352–6.
3. Bradley, J.S., Garau, J., Lode, H. et al. (1999). Carbapenems in clinical practice: a guide to their use in serious infection. Int J Antimicrob Agents11, 93–100.
4. Krumpe, P. E., Cohn, S., Garreltes, J. et al. (1999). Intravenous and oral mono- or combination-therapy in the treatment of severe infections: ciprofloxacin versus standard antibiotic therapy. Ciprofloxacin Study Group. J Antimicrob Chemother43, Suppl. A, 117–28.
5. File, T. M. Jr., Segreti, J., Dunbar, L. et al. (1997). A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia. Antimicrob Agents Chemother41, 1965–72.
Cited by
67 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献